undamentalytics Newsletter
Sign in

Trulieve Cannabis Corp. income statement

In fiscal 2025, Trulieve Cannabis Corp. reported revenue of $1.18bn, down 0.4% on the year before, operating income of $143m (a 12.1% margin) and net income of −$116m, or −$0.58 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue2535229321,2181,1291,1861,1811,139
Cost of revenue61135365529541471470462
Gross profit192386567689589716711677
Selling, general and administrative————386510445432
Selling and marketing59119212278————
General and administrative143699169————
Operating income11321820450−22298143−277
Interest expense920297382626357
Income before tax104157176−19−2854391−326
Income tax5194146163151198208145
Net income536317−253−527−155−116−473
Diluted EPS$0.46$0.53$0.21−$0.95−$2.28−$0.79−$0.58−$2.45
Diluted shares (average)115m118m147m188m189m190m191m193m
EBITDA118231250167−112211261−163

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: PBH vs TRLVANIP vs TRLVHRMY vs TRLVINDV vs TRLV

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Trulieve Cannabis Corp.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Trulieve Cannabis Corp.